BlackRock Institutional Trust’s GALENA BIOPHARMA INC COM RXII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-4,398,909
| Closed | -$1.54M | – | 3926 |
|
|
2016
Q3 | $1.54M | Buy |
4,398,909
+246,804
| +6% | +$86.5K | ﹤0.01% | 3140 |
|
|
2016
Q2 | $1.94M | Sell |
4,152,105
-45,903
| -1% | -$21.4K | ﹤0.01% | 3053 |
|
|
2016
Q1 | $5.71M | Buy |
4,198,008
+147,585
| +4% | +$201K | ﹤0.01% | 2582 |
|
|
2015
Q4 | $5.95M | Buy |
4,050,423
+87,696
| +2% | +$129K | ﹤0.01% | 2619 |
|
|
2015
Q3 | $6.26M | Sell |
3,962,727
-234,274
| -6% | -$370K | ﹤0.01% | 2587 |
|
|
2015
Q2 | $7.14M | Sell |
4,197,001
-56,437
| -1% | -$95.9K | ﹤0.01% | 2587 |
|
|
2015
Q1 | $5.91M | Buy |
4,253,438
+172,887
| +4% | +$240K | ﹤0.01% | 2695 |
|
|
2014
Q4 | $6.16M | Buy |
4,080,551
+101,910
| +3% | +$154K | ﹤0.01% | 2630 |
|
|
2014
Q3 | $8.2M | Buy |
3,978,641
+129,663
| +3% | +$267K | ﹤0.01% | 2448 |
|
|
2014
Q2 | $11.8M | Buy |
3,848,978
+220,445
| +6% | +$675K | ﹤0.01% | 2325 |
|
|
2014
Q1 | $9.07M | Buy |
3,628,533
+113,736
| +3% | +$284K | ﹤0.01% | 2484 |
|
|
2013
Q4 | $17.4M | Sell |
3,514,797
-144,556
| -4% | -$717K | ﹤0.01% | 2051 |
|
|
2013
Q3 | $8.34M | Buy |
3,659,353
+867,535
| +31% | +$1.98M | ﹤0.01% | 2469 |
|
|
2013
Q2 | $6.2M | Buy |
+2,791,818
| New | +$6.2M | ﹤0.01% | 2586 |
|